Article Information
History
- March 24, 2022.
Article Versions
- Version 1 (March 22, 2022 - 16:00).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Martina E. McMenamin1,
- Joshua Nealon1,*,
- Yun Lin1,
- Jessica Y. Wong1,
- Justin K. Cheung1,
- Eric H. Y. Lau1,2,
- Peng Wu1,2,
- Gabriel M. Leung1,2 and
- Benjamin J. Cowling1,2,*
- 1World Health Organization Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China
- 2Laboratory of Data Discovery for Health, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, China
- ↵*Corresponding authors:
Joshua Nealon (jnealon{at}hku.hk) and Ben Cowling (bcowling{at}hku.hk)
Posted March 24, 2022.
Vaccine effectiveness of two and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong
